Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Jackson Acquisition Co II (JACS)

Jackson Acquisition Co II closes $230 million IPO of 23 million units

Neutral Impact 3 of 5 financing Written later

Jackson Acquisition Company II, a blank check company focused on healthcare, closed its initial public offering on December 11, 2024, including the full exercise of the underwriter's over-allotment option. The company placed $232.3 million in a trust account, and it has 24 months from the IPO closing to complete a business combination or redeem public shares.

Key points

  • Sold 23,000,000 units at $10.00 each for gross proceeds of $230 million, including 3,000,000 over-allotment units.
  • Sold 840,000 private placement units for $8.4 million to RJ Healthcare SPAC II, LLC and Roth Capital Partners, LLC.
  • Placed $232.3 million in a trust account with Continental Stock Transfer & Trust Company, or $10.10 per Unit.

The filing

CompanyJackson Acquisition Co II (JACS)
Form8-K, current report
Filed with the SECDec 17, 2024, 4:15 PM ET
Accession number0001213900-24-109769

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 17, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.